Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Ireland has a golden opportunity to build on existing scientific, biomanufacturing, and clinical strengths and create a unique ecosystem to rival other, more established centres in Europe. The ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

(NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it has ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evolving research fields, including in drug delivery, cell therapy, ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...